IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status.
about
Dendritic cells as therapeutic targets in neuroinflammation.Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients.Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patientsProduction of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: Modulation of local immune responses.
P2860
IFN-β Therapy Regulates TLR7-Mediated Response in Plasmacytoid Dendritic Cells of Multiple Sclerosis Patients Influencing an Anti-Inflammatory Status.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
IFN-β Therapy Regulates TLR7-M ...... g an Anti-Inflammatory Status.
@en
type
label
IFN-β Therapy Regulates TLR7-M ...... g an Anti-Inflammatory Status.
@en
prefLabel
IFN-β Therapy Regulates TLR7-M ...... g an Anti-Inflammatory Status.
@en
P2093
P50
P356
P1476
IFN-β Therapy Regulates TLR7-M ...... g an Anti-Inflammatory Status.
@en
P2093
Elena Giacomini
Eliana Marina Coccia
Marco Salvetti
Valerie Gafa
Viviana Annibali
P304
P356
10.1089/JIR.2014.0207
P577
2015-04-29T00:00:00Z